2-6865638-C-G
Variant summary
Our verdict is Benign. Variant got -8 ACMG points: 0P and 8B. BP4_StrongBS2
The NM_207315.4(CMPK2):āc.59G>Cā(p.Arg20Pro) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000441 in 1,354,500 control chromosomes in the GnomAD database, including 3 homozygotes. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_207315.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -8 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CMPK2 | NM_207315.4 | c.59G>C | p.Arg20Pro | missense_variant | 1/5 | ENST00000256722.10 | NP_997198.2 | |
CMPK2 | NM_001256477.1 | c.59G>C | p.Arg20Pro | missense_variant | 1/4 | NP_001243406.1 | ||
CMPK2 | NM_001256478.1 | c.59G>C | p.Arg20Pro | missense_variant | 1/4 | NP_001243407.1 | ||
CMPK2 | NR_046236.2 | n.210+788G>C | intron_variant |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.000158 AC: 24AN: 151782Hom.: 0 Cov.: 35
GnomAD3 exomes AF: 0.000135 AC: 4AN: 29618Hom.: 0 AF XY: 0.000166 AC XY: 3AN XY: 18042
GnomAD4 exome AF: 0.000476 AC: 573AN: 1202718Hom.: 3 Cov.: 38 AF XY: 0.000473 AC XY: 278AN XY: 588036
GnomAD4 genome AF: 0.000158 AC: 24AN: 151782Hom.: 0 Cov.: 35 AF XY: 0.000162 AC XY: 12AN XY: 74146
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Aug 09, 2021 | The c.59G>C (p.R20P) alteration is located in exon 1 (coding exon 1) of the CMPK2 gene. This alteration results from a G to C substitution at nucleotide position 59, causing the arginine (R) at amino acid position 20 to be replaced by a proline (P). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at